What Happened?
Columbus, OH-based Forge Biologics Appointed Christina Perry as Senior Vice President, Finance and Investor Relations
About the Company
Forge is a gene therapy development engine, focused on enabling access to life changing gene therapies and helping bring them from idea into reality. We partner with innovators in the gene therapy community: scientists, physicians, biotech/pharma companies, and patient groups.
About the Person
Christina Perry is Senior Vice President, Finance and Investor Relations at Forge Biologics. Previously, Christina held various senior HR leadership roles in the industry.
Info Source
News
Short Profile